Note: Ingredients listed on restricted chemical lists
EC/CAS
111-46-6
Name of the chemical
diethyleneglycol
Concentration
1-5
EC/CAS
108-05-4
Name of the chemical
Vinylacetat (944/2013)
Concentration
0.1-1
General Information
Version
3
Revision date
2025-12-25
Product name
RESINA PRACKTICA V1
1.2.1 Relevant identified uses
Consumer applications
Manufacturer Name
PPG AP Resinas, SA de CV
Icons in SDS
Company Information
company name
PPG AP Resinas, SA de CV
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334, H351, H373
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
33.6% (oral), 33.6% (dermal), 36.5% (inhalation)
Signal word
Danger
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. (kidneys)
Precautionary statements
General : Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Wear respiratory protection. Do not breathe vapor.
Response
IF exposed or concerned Get medical advice or attention. IF INHALED Remove person to fresh air and keep comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Emits toxic fumes when heated.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 33.6% (oral), 33.6% (dermal), 36.5% (inhalation)
